Investor Relations 560 Sylvan Ave Suite 3160 Englewood Cliffs, NJ 07632
Shareholders and interested parties may communicate directly with the Board of Directors, the Audit Committee of the Board of Directors with respect to accounting issues, questionable accounting or auditing matters or internal accounting controls, any other Board committee, any individual Director, any group of Directors or the Lead Independent Director by e-mailing firstname.lastname@example.org.
Reports may be made anonymously or confidentially.
You are about to review presentations, reports and/or filings of Silo Pharma, Inc. , that contain time-sensitive information. The information contained therein is only accurate as of the date thereof. Silo Pharma, Inc. will not be reviewing or updating the material that is contained in these items after the date thereof. The information contained therein may be updated, amended, supplemented or otherwise altered by subsequent presentations, reports and/or filings by Silo Pharma, Inc.
I Accept I Decline